{"doi":"10.3390/v11010082","title":"Establishment of an Alphavirus-Specific Neutralization Assay to Distinguish Infections with Different Members of the Semliki Forest Complex","abstract":"<jats:p>Background: Alphaviruses are transmitted by arthropod vectors and can be found worldwide. Alphaviruses of the Semliki Forest complex such as chikungunya virus (CHIKV), Mayaro virus (MAYV) or Ross River virus (RRV) cause acute febrile illness and long-lasting arthralgia in humans, which cannot be clinically discriminated from a dengue virus or Zika virus infection. Alphaviruses utilize a diverse array of mosquito vectors for transmission and spread. For instance, adaptation of CHIKV to transmission by Aedes albopictus has increased its spread and resulted in large outbreaks in the Indian Ocean islands. For many alphaviruses commercial diagnostic tests are not available or show cross-reactivity among alphaviruses. Climate change and globalization will increase the spread of alphaviruses and monitoring of infections is necessary and requires virus-specific methods. Method: We established an alphavirus neutralization assay in a 384-well format by using pseudotyped lentiviral vectors. Results: MAYV-specific reactivity could be discriminated from CHIKV reactivity. Human plasma from blood donors infected with RRV could be clearly identified and did not cross-react with other alphaviruses. Conclusion: This safe and easy to use multiplex assay allows the discrimination of alphavirus-specific reactivity within a single assay and has potential for epidemiological surveillance. It might also be useful for the development of a pan-alphavirus vaccine.</jats:p>","journal":"Viruses","year":2019,"id":16646,"datarank":1.267961907280541,"base_score":4.204692619390966,"endowment":4.204692619390966,"self_citation_contribution":0.6307038929086449,"citation_network_contribution":0.6372580143718962,"self_endowment_contribution":0.6307038929086449,"citer_contribution":0.6372580143718962,"corpus_percentile":null,"corpus_rank":null,"citation_count":66,"citer_count":54,"citers_with_citation_signal":23,"citers_with_endowment":23,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":122095,"name":"Constanze Yue","orcid":null,"position":1,"is_corresponding":false},{"id":122096,"name":"Joshua Kandler","orcid":null,"position":2,"is_corresponding":false},{"id":122097,"name":"Helen M. Faddy","orcid":null,"position":3,"is_corresponding":false},{"id":122098,"name":"Graham Simmons","orcid":null,"position":4,"is_corresponding":false},{"id":122099,"name":"Marcus Panning","orcid":"0000-0003-3596-5964","position":5,"is_corresponding":false},{"id":122100,"name":"Lia Laura Lewis-Ximenez","orcid":null,"position":6,"is_corresponding":false},{"id":122101,"name":"Sally A. Baylis","orcid":null,"position":7,"is_corresponding":false},{"id":122102,"name":"Barbara S. Schnierle","orcid":null,"position":8,"is_corresponding":false},{"id":122094,"name":"Lisa Henss","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":4.204692619390966,"endowment":4.204692619390966,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"30669393","pmcid":"PMC6356848","openalex_id":"https://openalex.org/W2910205609","authors":[],"funders":[{"funder_name":"Bundesamt für Gesundheit","grant_id":"ZMV I 1 - 25 17 FSB 413","title":null},{"funder_name":"National Institutes of Health","grant_id":"R01 AI119056","title":null},{"funder_name":"National Institutes of Health","grant_id":"5R01AI119056-04","title":"Protective B-cell responses in chikungunya virus infection"}],"total_grants":3,"fwci":12.3793,"citation_percentile":0.99044166,"influential_citations":0,"citation_trend":[{"year":2019,"count":37},{"year":2020,"count":3},{"year":2021,"count":7},{"year":2022,"count":8},{"year":2023,"count":4},{"year":2024,"count":3},{"year":2025,"count":2},{"year":2026,"count":2}],"oa_status":"gold","license":"cc-by","oa_locations":[{"url":"https://www.mdpi.com/1999-4915/11/1/82/pdf?version=1548140064","host_type":"journal"},{"url":"https://www.mdpi.com/1999-4915/11/1/82/pdf?version=1548140064","host_type":"GOLD"},{"url":"https://www.mdpi.com/1999-4915/11/1/82/pdf?version=1548140064","host_type":"publisher"},{"url":"https://www.mdpi.com/1999-4915/11/1/82/pdf","host_type":"publisher"},{"url":"https://doi.org/10.3390/v11010082","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/30669393","host_type":"repository"},{"url":"http://americanae.aecid.es/americanae/es/registros/registro.do?tipoRegistro=MTD&idBib=2324371","host_type":"repository"},{"url":"https://arca.fiocruz.br/handle/icict/31963","host_type":"repository"},{"url":"https://doaj.org/article/9e72a90a6f89444eb2165ef94705234b","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6356848","host_type":"repository"},{"url":"http://doi.org/10.3390/v11010082","host_type":"repository"},{"url":"http://dx.doi.org/10.3390/v11010082","host_type":"repository"},{"url":"https://www.arca.fiocruz.br/handle/icict/31963","host_type":"repository"},{"url":"https://europepmc.org/articles/PMC6356848","host_type":"Europe_PMC"},{"url":"https://europepmc.org/articles/PMC6356848?pdf=render","host_type":"Europe_PMC"},{"url":"https://dx.doi.org/10.3390/v11010082","host_type":""},{"url":"https://doi.org/https://doi.org/10.3390/v11010082","host_type":""}],"fields_of_study":["Mosquito-borne diseases and control","Viral Infections and Outbreaks Research","Dengue and Mosquito Control Research","Biology","Medicine","0301 basic medicine","03 medical and health sciences","0303 health sciences","Alphavirus Infections","Animals","Chikungunya virus","Cross Reactions","Enzyme-Linked Immunosorbent Assay","Humans","Inhibitory Concentration 50","Mosquito Vectors","Neutralization Tests","Ross River virus","Semliki forest virus","Sensitivity and Specificity"],"mesh_terms":["Mosquito Vectors","Animals","Chikungunya virus","Cross Reactions","Enzyme-Linked Immunosorbent Assay","Humans","Neutralization Tests","Ross River virus","Semliki forest virus","Sensitivity and Specificity","Alphavirus Infections","Inhibitory Concentration 50"],"keywords":["Semliki Forest virus","Alphavirus","Neutralization","Virology","Alphavirus infection","Biology","Virus","Genetics","RNA","lentiviral vector","Pseudotyping","Neutralization Assay","570","Enzyme-Linked Immunosorbent Assay","Mosquito Vectors","Cross Reactions","Microbiology","Sensitivity and Specificity","Article","Inhibitory Concentration 50","Neutralization Tests","Ross River virus","Animals","Humans","Lentiviren","Viren","Alphavirus Infections","QR1-502","FoR 0605 (Microbiology)","Chikungunya virus"],"sdg_mappings":[{"sdg_number":3,"sdg_label":"3. Good health"},{"sdg_number":13,"sdg_label":"13. Climate action"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[{"name":"gen"},{"name":"uniprot"}],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-02T12:18:30.606216Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}